UK markets close in 2 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7090-0.0610 (-3.45%)
As of 10:11AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
56,832
56,832
62,521
81,149
101,980
Cost of revenue
37,382
37,382
45,253
47,695
53,400
Gross profit
19,450
19,450
17,268
33,454
48,580
Operating expenses
Research development
4,379
4,379
4,138
4,497
5,080
Selling general and administrative
31,152
31,152
26,983
22,503
27,499
Total operating expenses
35,393
35,393
30,788
27,000
30,722
Operating income or loss
-15,943
-15,943
-13,520
6,454
17,858
Interest expense
10,148
10,148
11,532
5,447
5,535
Total other income/expenses net
-11,102
-11,102
-15,507
-2,516
-17,776
Income before tax
-36,927
-36,927
-43,780
-1,924
-6,633
Income tax expense
-59
-59
-194
-74
-620
Income from continuing operations
-36,868
-36,868
-43,586
-1,850
-6,013
Net income
-24,018
-24,018
-41,009
875
-6,388
Net income available to common shareholders
-24,018
-24,018
-41,009
875
-6,388
Basic EPS
-0.76
-
-6.00
0.20
-1.60
Diluted EPS
-0.76
-
-6.00
0.20
-1.60
Basic average shares
38,201
-
6,747
4,180
4,180
Diluted average shares
38,201
-
7,775
5,326
4,180